Five Prime Therapeutics

/Five Prime Therapeutics

They are a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics.

Symbol

Last Closing Price
$20.14

Shares
3,400,000

Effective Date
January 25, 2018

Underwriters

To view the prospectus for , or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange